CVS Health Corporation (CVS)

67.6 -0.04%
02:55 pm EDT; Powered by Koyfin
Pros
Stock price low relative to the 52-week range
Revenue growth higher than the industry and sector averages
Forward dividend yield higher than the industry and sector averages
Forward P/E ratio low relative to industry peers
Forward P/B ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
Forward PEG ratio high relative to industry peers

Pros

  1. CVS stock price ($73.89) is close to the 52-week low ($72.26). Perhaps now is a good time to buy? See CVS price chart.
  2. CVS quarterly revenue growth was 9.60%, higher than the industry and sector average revenue growth (9.28% and 3.00%, respectively). See CVS revenue growth chart.
  3. CVS forward dividend yield is 3.31%, higher than the industry (0.46%) and sector (0.21%) forward dividend yields. See CVS forward dividend chart.
  4. CVS forward P/E ratio is 8.07, which is low compared to its industry peers’ P/E ratios. See CVS forward P/E ratio chart.
  5. CVS Price/Book ratio is 1.34, which is low compared to its industry peers’ P/B ratios. See CVS forward Price/Book ratio chart.
  6. CVS average analyst rating is Buy. See CVS analyst rating chart.
  7. CVS average analyst price target ($119.12) is above its current price ($73.89). See CVS price target chart.

Cons

  1. CVS PEG ratio (P/E adjusted for growth) is 1.67, which is high compared to its industry peers’ PEG ratios. See CVS PEG chart.